文献速递临床试验与 GCP

分期Turnbull-Cutait拖出式吻合与直接吻合加预防性回肠造口在括约肌间切除术后低位直肠癌治疗中的比较(STAR-TAR):一项随机对照试验的研究方案

Staged Turnbull-Cutait pull-through anastomosis comparing with direct anastomosis plus prophylactic ileostomy in the treatment of low rectal cancer after internal sphincter resection (STAR-TAR): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2025-05-22

本研究为前瞻性、多中心、1:1、非劣效性随机对照试验,纳入110例低位直肠癌患者,比较分期Turnbull-Cutait拖出式吻合(n=55)与直接吻合加预防性回肠造口(n=55)在括约肌间切除术后的并发症、肿瘤学结局和功能结果。主要结局为30天术后总体并发症率。现有该技术证据多来自小型单中心回顾性研究,证据等级低,需多中心随机试验提供更高质量证据。

要点

  • 比较分期Turnbull-Cutait拖出式吻合与直接吻合加预防性回肠造口在括约肌间切除术后的效果。
  • 主要结局为30天术后总体并发症率,包括吻合口漏、感染等。
  • 现有证据限于小型单中心回顾性研究,需多中心随机试验验证。

核心结论

  • 目前缺乏系统研究探索延迟拖出式吻合在括约肌间切除术中的应用,现有多为小型单中心回顾性研究,证据等级低。
  • 需多中心前瞻性随机对照试验确定延迟拖出式吻合能否作为括约肌间切除结肠肛管吻合的可行替代方案,提供相当或更低的术后并发症率及相似的肿瘤学结局和排便功能。

研究设计与样本

  • 前瞻性、多中心、1:1、非劣效性随机对照试验,共110例参与者,分为分期Turnbull-Cutait拖出式吻合组(n=55)和直接吻合组(n=55)。
  • 对照组行括约肌间切除加传统吻合加预防性回肠造口,试验组行经肛拖出式延迟吻合不加回肠造口。

主要发现

  • 主要结局为30天术后总体并发症率,包括吻合口漏、感染及其他并发症。
  • 次要结局包括远期并发症、总手术时间、肛门直肠功能(LARS和Wexner评分)、泌尿和性功能、生活质量(EORTC QLQ-CR29和FIQL)以及3年无病生存期(DFS)和总生存期(OS)。

临床怎么用

  • 原文未据此给出推荐,结论指出需多中心前瞻性随机对照试验确定延迟拖出式吻合能否作为括约肌间切除结肠肛管吻合的可行替代方案。

局限性

  • 现有该技术研究限于小型、单中心、回顾性研究,证据等级低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Recent advancements in the understanding of lower rectum anatomy, rectal cancer biology, and surgical techniques have emphasized the importance of radical surgery for low rectal cancer that balances oncological safety and anal function preservation. After total mesorectal excision (TME) and coloanal anastomosis, participants face high risks of anastomotic leakage and infection, often requiring a protective ileostomy. However, ileostomies themselves lead to significant complications, such as dehydration and chronic renal failure, and many participants cannot have their stomas reversed as planned. The Turnbull-Cutait procedure, involving delayed transanal pull-through rectal resection, has emerged as a safer alternative, reducing leakage complications and avoiding the need for a protective stoma. Recent studies support its use in challenging rectal cases, showing comparable or better outcomes than standard techniques. Despite these promising results, limited data exists on its application to intersphincteric resection (ISR) or intersphincteric dissection (ISD), which itself has higher complication rates. Therefore, further research is needed to evaluate this Turnbull-Cutait anastomosis procedure (delayed transanal pull-through) in ISR, comparing its complications, oncological outcomes, and functional results to those of traditional methods (direct anastomosis). This study is a prospective, multicenter, 1:1, non-inferiority, randomized controlled trial with 110 participants, divided into two groups: the staged Turnbull-Cutait pull-through anastomosis group (n = 55) and the direct anastomosis group (n = 55). The control group will undergo ISR with traditional anastomosis plus protective ileostomy, while the experimental group will receive the transanal pull-through and delayed anastomosis without ileostomy. The primary outcome is the 30-day overall postoperative complication rate, including anastomotic leakage, infection, and other complications. Secondary outcomes include long-term complications, total surgery time, anorectal function (measured by LARS and Wexner scores), urinary and sexual function, quality of life (EORTC QLQ-CR29 and FIQL), and 3-year disease-free survival (DFS) and overall survival (OS). DISCUSSION: Currently, there is a lack of systematic studies exploring the use of delayed pull-through anastomosis in intersphincteric resection (ISR) procedures. Existing research on this technique in low rectal cancer is limited to small, single-center, retrospective studies with low levels of evidence. Therefore, a multicenter, prospective, randomized controlled trial is needed to determine whether delayed pull-through anastomosis can serve as a viable alternative to ISR-coloanal anastomosis, offering comparable or lower rates of postoperative complications, as well as similar oncological outcomes and defecatory function. This study aims to provide higher-quality evidence through a larger, well-designed trial, which could significantly inform clinical practice in this under-explored area. TRIAL REGISTRATION: ClinicalTrials.gov NCT06662643. Registered on October 29, 2024.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Chen W, Ding J, Xiang J, et al. Staged Turnbull-Cutait pull-through anastomosis comparing with direct anastomosis plus prophylactic ileostomy in the treatment of low rectal cancer after internal sphincter resection (STAR-TAR): study protocol for a randomized controlled trial. Trials. 2025. PMID: 40405283. doi:10.1186/s13063-025-08845-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。